Clinical Focus ›› 2026, Vol. 41 ›› Issue (2): 128-134.doi: 10.3969/j.issn.1004-583X.2026.02.005
Previous Articles Next Articles
Zhao Lingyan1(
), Shi Xueling1, Xian Yanyan1, Li Jingjing2
Received:2025-12-11
Online:2026-02-20
Published:2026-03-05
Contact:
Zhao Lingyan, Email:zly691562@126.com
CLC Number:
Zhao Lingyan, Shi Xueling, Xian Yanyan, Li Jingjing. Trajectory analysis of quality-of-life decline and identification of associated risk factors in elderly patients with chronic heart failure[J]. Clinical Focus, 2026, 41(2): 128-134.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.02.005
| 项目 | 例数(例) | 构成比(%) |
|---|---|---|
| 性别 | ||
| 男 女 | 119 78 | 60.41 39.59 |
| 年龄 | ||
| <75岁 ≥75岁 | 101 96 | 51.27 48.73 |
| 文化程度 | ||
| 小学及以下 | 36 | 18.27 |
| 初中与高中 | 127 | 64.47 |
| 大专及以上 | 34 | 17.26 |
| 居住状态 | ||
| 独居 非独居 | 35 162 | 17.77 82.23 |
| 病程 | ||
| <1年 | 45 | 22.84 |
| ≥1~<5年 | 61 | 30.96 |
| ≥5~<10年 | 71 | 36.04 |
| ≥10年 | 20 | 10.15 |
| LVEF≤35% | ||
| 是 否 | 83 114 | 42.13 57.87 |
| 治疗后心功能分级 | ||
| Ⅰ级 | 14 | 7.11 |
| Ⅱ级 | 65 | 32.99 |
| Ⅲ级 | 93 | 47.21 |
| Ⅳ级 | 25 | 12.69 |
| 合并病症及指标异常情况 | ||
| 合并肾功能不全 | 85 | 43.15 |
| 合并高血脂 | 64 | 32.49 |
| 合并尿素氮升高 | 35 | 17.77 |
| 合并血肌酐升高 | 36 | 18.27 |
| 合并糖化血红蛋白升高 | 46 | 23.35 |
| 合并血清总蛋白降低 | 42 | 21.32 |
| 合并营养不良 | 32 | 16.24 |
| 合并血小板减少 | 30 | 15.23 |
| 合并淋巴细胞计数降低 | 54 | 27.41 |
| 合并高血钠 | 67 | 34.01 |
| 合并低血钾 | 48 | 24.37 |
| 合并谷氨酰胺转移酶升高 | 55 | 27.92 |
| 合并脑钠肽升高 | 38 | 19.29 |
| 合并贫血 | 72 | 36.55 |
| 生活习惯及治疗相关情况 | ||
| 按时按量服药 | 145 | 73.60 |
| 低钠限水饮食 | 129 | 65.48 |
| 规律有氧运动 | 75 | 38.07 |
| 抑郁 | 68 | 34.52 |
Tab.1 General information of elderly patients with CHF
| 项目 | 例数(例) | 构成比(%) |
|---|---|---|
| 性别 | ||
| 男 女 | 119 78 | 60.41 39.59 |
| 年龄 | ||
| <75岁 ≥75岁 | 101 96 | 51.27 48.73 |
| 文化程度 | ||
| 小学及以下 | 36 | 18.27 |
| 初中与高中 | 127 | 64.47 |
| 大专及以上 | 34 | 17.26 |
| 居住状态 | ||
| 独居 非独居 | 35 162 | 17.77 82.23 |
| 病程 | ||
| <1年 | 45 | 22.84 |
| ≥1~<5年 | 61 | 30.96 |
| ≥5~<10年 | 71 | 36.04 |
| ≥10年 | 20 | 10.15 |
| LVEF≤35% | ||
| 是 否 | 83 114 | 42.13 57.87 |
| 治疗后心功能分级 | ||
| Ⅰ级 | 14 | 7.11 |
| Ⅱ级 | 65 | 32.99 |
| Ⅲ级 | 93 | 47.21 |
| Ⅳ级 | 25 | 12.69 |
| 合并病症及指标异常情况 | ||
| 合并肾功能不全 | 85 | 43.15 |
| 合并高血脂 | 64 | 32.49 |
| 合并尿素氮升高 | 35 | 17.77 |
| 合并血肌酐升高 | 36 | 18.27 |
| 合并糖化血红蛋白升高 | 46 | 23.35 |
| 合并血清总蛋白降低 | 42 | 21.32 |
| 合并营养不良 | 32 | 16.24 |
| 合并血小板减少 | 30 | 15.23 |
| 合并淋巴细胞计数降低 | 54 | 27.41 |
| 合并高血钠 | 67 | 34.01 |
| 合并低血钾 | 48 | 24.37 |
| 合并谷氨酰胺转移酶升高 | 55 | 27.92 |
| 合并脑钠肽升高 | 38 | 19.29 |
| 合并贫血 | 72 | 36.55 |
| 生活习惯及治疗相关情况 | ||
| 按时按量服药 | 145 | 73.60 |
| 低钠限水饮食 | 129 | 65.48 |
| 规律有氧运动 | 75 | 38.07 |
| 抑郁 | 68 | 34.52 |
| 模型 | AIC | BIC | aBIC | Entropy | BLRT(P值) | LMR(P值) | 类别占比(%) |
|---|---|---|---|---|---|---|---|
| 1 | 3 862.541 | 3 881.263 | 3 867.542 | - | - | - | 100.00 |
| 2 | 3 518.732 | 3 549.876 | 3 528.345 | 0.821 | <0.01 | <0.01 | 32.49/67.51 |
| 3 | 3 205.418 | 3 248.974 | 3 219.632 | 0.872 | <0.01 | <0.01 | 17.77/61.42/20.81 |
| 4 | 3 189.653 | 3 245.621 | 3 208.478 | 0.833 | 0.156 | 0.214 | 15.23/58.37/4.57/21.83 |
| 5 | 3 176.892 | 3 245.273 | 3 200.329 | 0.827 | 0.203 | 0.286 | 14.16/55.84/3.04/18.27/8.69 |
Tab.2 Fitting results of the QOL trajectory model in elderly patients with CHF
| 模型 | AIC | BIC | aBIC | Entropy | BLRT(P值) | LMR(P值) | 类别占比(%) |
|---|---|---|---|---|---|---|---|
| 1 | 3 862.541 | 3 881.263 | 3 867.542 | - | - | - | 100.00 |
| 2 | 3 518.732 | 3 549.876 | 3 528.345 | 0.821 | <0.01 | <0.01 | 32.49/67.51 |
| 3 | 3 205.418 | 3 248.974 | 3 219.632 | 0.872 | <0.01 | <0.01 | 17.77/61.42/20.81 |
| 4 | 3 189.653 | 3 245.621 | 3 208.478 | 0.833 | 0.156 | 0.214 | 15.23/58.37/4.57/21.83 |
| 5 | 3 176.892 | 3 245.273 | 3 200.329 | 0.827 | 0.203 | 0.286 | 14.16/55.84/3.04/18.27/8.69 |
| 项目 | 持续低水平组(n=35) | 缓慢下降组(n=121) | 快速下降组(n=41) | χ2值 | P值 |
|---|---|---|---|---|---|
| 年龄(岁) | |||||
| <75 ≥75 | 30(85.71) 5(14.29) | 68(56.20) 53(43.80) | 3(7.32) 38(92.68) | 49.500 | <0.01 |
| 治疗后心功能分级 | |||||
| Ⅰ级 | 6(17.14) | 7(5.79) | 1(2.44) | ||
| Ⅱ级 | 18(51.43) | 40(33.06) | 7(17.07) | 66.112 | <0.01 |
| Ⅲ级 | 8(22.86) | 65(53.72) | 10(24.39) | ||
| Ⅳ级 | 3(8.57) | 9(7.44) | 23(56.10) | ||
| LVEF≤35% | |||||
| 是 否 | 2(5.71) 33(94.29) | 52(42.89) 69(57.02) | 29(70.73) 12(29.27) | 32.829 | <0.01 |
| 合并肾功能不全 | |||||
| 是 否 | 3(8.57) 32(91.43) | 55(45.45) 66(54.55) | 27(65.85) 14(34.15) | 25.937 | <0.01 |
| 合并贫血 | |||||
| 是 否 | 1(2.86) 34(97.14) | 48(39.67) 73(60.33) | 23(56.10) 18(43.90) | 24.396 | <0.01 |
| 按时按量服药 | |||||
| 是 否 | 32(91.43) 3(8.57) | 90(74.38) 31(25.62) | 23(56.10) 18(43.90) | 12.229 | 0.002 |
| 规律有氧运动 | |||||
| 是 否 | 29(82.86) 6(17.14) | 42(34.71) 79(65.29) | 4(9.76) 37(90.24) | 44.298 | <0.01 |
| 抑郁 | |||||
| 是 否 | 3(8.57) 32(91.43) | 36(29.75) 85(70.25) | 29(70.73) 12(29.27) | 35.429 | <0.01 |
Tab.3 Univariate analysis of QOL trajectory categories in elderly patients with CHF (n, %)
| 项目 | 持续低水平组(n=35) | 缓慢下降组(n=121) | 快速下降组(n=41) | χ2值 | P值 |
|---|---|---|---|---|---|
| 年龄(岁) | |||||
| <75 ≥75 | 30(85.71) 5(14.29) | 68(56.20) 53(43.80) | 3(7.32) 38(92.68) | 49.500 | <0.01 |
| 治疗后心功能分级 | |||||
| Ⅰ级 | 6(17.14) | 7(5.79) | 1(2.44) | ||
| Ⅱ级 | 18(51.43) | 40(33.06) | 7(17.07) | 66.112 | <0.01 |
| Ⅲ级 | 8(22.86) | 65(53.72) | 10(24.39) | ||
| Ⅳ级 | 3(8.57) | 9(7.44) | 23(56.10) | ||
| LVEF≤35% | |||||
| 是 否 | 2(5.71) 33(94.29) | 52(42.89) 69(57.02) | 29(70.73) 12(29.27) | 32.829 | <0.01 |
| 合并肾功能不全 | |||||
| 是 否 | 3(8.57) 32(91.43) | 55(45.45) 66(54.55) | 27(65.85) 14(34.15) | 25.937 | <0.01 |
| 合并贫血 | |||||
| 是 否 | 1(2.86) 34(97.14) | 48(39.67) 73(60.33) | 23(56.10) 18(43.90) | 24.396 | <0.01 |
| 按时按量服药 | |||||
| 是 否 | 32(91.43) 3(8.57) | 90(74.38) 31(25.62) | 23(56.10) 18(43.90) | 12.229 | 0.002 |
| 规律有氧运动 | |||||
| 是 否 | 29(82.86) 6(17.14) | 42(34.71) 79(65.29) | 4(9.76) 37(90.24) | 44.298 | <0.01 |
| 抑郁 | |||||
| 是 否 | 3(8.57) 32(91.43) | 36(29.75) 85(70.25) | 29(70.73) 12(29.27) | 35.429 | <0.01 |
| 自变量 | 赋值方式 |
|---|---|
| 年龄 | 0=<75岁,1=≥75岁 |
| 治疗后心功能分级 | 0=Ⅰ级,1=Ⅱ级,2=Ⅲ级,3=Ⅳ级 |
| LVEF≤35% | 0=否,1=是 |
| 合并肾功能不全 | 0=否,1=是 |
| 合并贫血 | 0=否,1=是 |
| 按时按量服药 | 0=否,1=是 |
| 规律有氧运动 | 0=否,1=是 |
| 抑郁 | 0=否,1=是 |
Tab.4 Assignment of independent variables
| 自变量 | 赋值方式 |
|---|---|
| 年龄 | 0=<75岁,1=≥75岁 |
| 治疗后心功能分级 | 0=Ⅰ级,1=Ⅱ级,2=Ⅲ级,3=Ⅳ级 |
| LVEF≤35% | 0=否,1=是 |
| 合并肾功能不全 | 0=否,1=是 |
| 合并贫血 | 0=否,1=是 |
| 按时按量服药 | 0=否,1=是 |
| 规律有氧运动 | 0=否,1=是 |
| 抑郁 | 0=否,1=是 |
| 变量 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|
| 截距 | 1.025 | 0.287 | 12.643 | - | - | <0.01 |
| 年龄≥75岁 | 1.352 | 0.318 | 18.267 | 3.863 | 2.015~7.406 | <0.01 |
| 治疗后心功能分级(Ⅳ级) | 1.426 | 0.335 | 18.209 | 4.167 | 2.158~8.045 | <0.01 |
| LVEF≤35% | 1.513 | 0.349 | 18.762 | 4.548 | 2.347~8.812 | <0.01 |
| 合并肾功能不全 | 1.487 | 0.332 | 19.845 | 4.432 | 2.315~8.483 | <0.01 |
| 合并贫血 | 1.459 | 0.341 | 18.536 | 4.293 | 2.228~8.269 | <0.01 |
| 按时按量服药 | -1.403 | 0.326 | 18.674 | 0.246 | 0.129~0.469 | <0.01 |
| 规律有氧运动 | -1.532 | 0.354 | 18.927 | 0.216 | 0.111~0.419 | <0.01 |
| 抑郁 | 1.506 | 0.338 | 19.873 | 4.512 | 2.339~8.702 | <0.01 |
Tab.5 Multivariate ordinal logistic regression analysis of QOL trajectory categories in elderly patients with CHF
| 变量 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|
| 截距 | 1.025 | 0.287 | 12.643 | - | - | <0.01 |
| 年龄≥75岁 | 1.352 | 0.318 | 18.267 | 3.863 | 2.015~7.406 | <0.01 |
| 治疗后心功能分级(Ⅳ级) | 1.426 | 0.335 | 18.209 | 4.167 | 2.158~8.045 | <0.01 |
| LVEF≤35% | 1.513 | 0.349 | 18.762 | 4.548 | 2.347~8.812 | <0.01 |
| 合并肾功能不全 | 1.487 | 0.332 | 19.845 | 4.432 | 2.315~8.483 | <0.01 |
| 合并贫血 | 1.459 | 0.341 | 18.536 | 4.293 | 2.228~8.269 | <0.01 |
| 按时按量服药 | -1.403 | 0.326 | 18.674 | 0.246 | 0.129~0.469 | <0.01 |
| 规律有氧运动 | -1.532 | 0.354 | 18.927 | 0.216 | 0.111~0.419 | <0.01 |
| 抑郁 | 1.506 | 0.338 | 19.873 | 4.512 | 2.339~8.702 | <0.01 |
| [1] | Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines[J]. Circulation, 2022, 145(18):e895-e1032.doi: 10.1161/CIR.0000000000001142. |
| [2] |
Bekelman DB, Feser W, Morgan B, et al. Nurse and social worker palliative telecare team and quality of life in patients with copd, heart failure, or interstitial lung disease: The adapt randomized clinical trial[J]. JAMA, 2024, 331(3):212-223.doi: 10.1001/jama.2023.24035.
pmid: 38227034 |
| [3] | Jaarsma T, Hill L, Bayes-Genis A, et al. Self-care of heart failure patients: Practical management recommendations from the heart failure association of the european society of cardiology[J]. Eur J Heart Fail, 2021, 23(1):157-174.doi: 10.1002/ejhf.2008. |
| [4] | Alexanian M, Padmanabhan A, Nishino T, et al. Chromatin remodelling drives immune cell-fibroblast communication in heart failure[J]. Nature, 2024, 635(8038):434-443.doi: 10.1038/s41586-024-08085-6. |
| [5] | Gergely TG, Drobni ZD, Kallikourdis M, et al. Immune checkpoints in cardiac physiology and pathology: Therapeutic targets for heart failure[J]. Nat Rev Cardiol, 2024, 21(7):443-462.doi: 10.1038/s41569-023-00986-9. |
| [6] | 赵一瑾, 田晶, 闫晶晶, 等. 慢性心衰患者报告结局恶化与最小显著差异之TUDD纵向分析[J]. 中国卫生统计, 2024, 41(2):239-243.doi:10.11783/j.issn.1002-3674.2024.02.017. |
| [7] | 王志燕, 陈晨, 吕强, 等. 2021年ESC急慢性心力衰竭诊断与治疗指南解读[J]. 中华心血管病杂志, 2021, 49(12):4.doi:10.3760/cma.j.cn112148-20210929-00840. |
| [8] |
Costa RVC. Nyha classification and cardiopulmonary exercise test variables in patients with heart failure[J]. Arq Bras Cardiol, 2022, 118(6):1124-1125.doi: 10.36660/abc.20220196.
pmid: 35703650 |
| [9] | Cong J, Zhu Y, Du J, et al. Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to SF-6Dv2 in chinese patients with heart failure[J]. Health Qual Life Outcomes, 2022, 20(1):98.doi: 10.1186/s12955-022-02004-x. |
| [10] | Wohlfahrt P, Jenˇca D, Stehlik J, et al. Heart failure-related quality-of-life impairment after myocardial infarction[J]. Clin Res Cardiol, 2023, 112(1):39-48.doi: 10.1007/s00392-022-02008-z. |
| [11] | Fatrin S, Okwose NC, Bailey K, et al. Haemodynamic determinants of quality of life in chronic heart failure[J]. BMC Cardiovasc Disord, 2022, 22(1):412.doi: 10.1186/s12872-022-02829-w. |
| [12] |
Herrmann JJ, Beckers-Wesche F, Baltussen LEHJM, et al. Fluid restriction in heart failure vs liberal fluid uptake: Rationale and design of the randomized fresh-up study[J]. J Card Fail, 2022, 28(10):1522-1530.doi: 10.1016/j.cardfail.2022.05.015.
pmid: 35705150 |
| [13] | Chávez-Iñiguez JS, Sánchez-Villaseca SJ, García-Macías LA. Cardiorenal syndrome: Classification, pathophysiology, diagnosis and management. Literature review[J]. Arch Cardiol Mex, 2022, 92(2):253-263.doi: 10.24875/ACM.20000183. |
| [14] | Dellafiore F, Chung ML, Alvaro R, et al. Influence of mutuality on quality of life in heart failure patient with inadequate self-care and caregiver dyads: An actor-partner interdependence model analysis[J]. Eur J Cardiovasc Nurs, 2022, 21(4):366-373.doi: 10.1093/eurjcn/zvab089. |
| [15] | Hicks S, Davidson M, Efstathiou N, et al. Effectiveness and cost effectiveness of palliative care interventions in people with chronic heart failure and their caregivers:A systematic review[J]. BMC Palliat Care, 2022, 21(1):205.doi: 10.1186/s12904-022-01092-2. |
| [16] | Zhang N, Li Q, Chen S, et al. Effectiveness of nurse-led electronic health interventions on illness management in patients with chronic heart failure: A systematic review and meta-analysis[J]. Int J Nurs Stud, 2024, 150:104630.doi: 10.1016/j.ijnurstu.2024.104913. |
| [17] | Helal SI, Lee G, Evans C, et al. The efficacy of psychological interventions on health-related quality of life for patients with heart failure and depression: A systematic review[J]. J Cardiovasc Nurs, 2022, 37(2):134-145.doi: 10.1097/JCN.0000000000000779. |
| [18] | Veskovic J, Cvetkovic M, Tahirovic E, et al. Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure[J]. BMC Cardiovasc Disord, 2023, 23(1):525.doi: 10.1186/s12872-023-03500-8. |
| [19] |
Yamamoto S, Okamura M, Akashi YJ, et al. Impact of long-term exercise-based cardiac rehabilitation in patients with chronic heart failure-a systematic review and meta-analysis[J]. Circ J, 2024, 88(9):1360-1371.doi: 10.1253/circj.CJ-23-0820.
pmid: 38220206 |
| [20] | Mei B, Yuan L, Shu Y. Quantitative evidence of the effect of baduanjin exercise on quality of life and cardiac function in adults with chronic heart failure[J]. Complement Ther Clin Pract, 2023, 53:101775.doi: 10.1016/j.ctcp.2023.101775. |
| [21] | Wang F, Bai Y, Hua B, et al. Effect of different intensity exercises on cardiopulmonary function and quality of life of patients with chronic heart failure: A systematic review and meta-analysis[J]. Herz, 2024, 49(2):134-146.doi: 10.1007/s00059-023-05202-5. |
| [22] | Wang L, Zhao Y, Han L, et al. Pharmacist-led management model and medication adherence among patients with chronic heart failure: A randomized clinical trial[J]. JAMA Netw Open, 2024, 7(12):e2453976.doi: 10.1001/jamanetworkopen.2024.53976. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||